CoreCap Advisors’s BioNTech BNTX Stock Holding History

CoreCap Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.26K	Hold	84	–	–	﹤0.01%	2120
2026 Q2	$7.82K	Hold	84	–	–	﹤0.01%	2156
2026 Q1	$7.47K	Hold	84	–	–	﹤0.01%	2058
2025 Q4	$8K	Hold	84	–	–	﹤0.01%	2044
2025 Q3	$8.28K	Hold	84	–	–	﹤0.01%	2015
2025 Q2	$8.94K	Hold	84	–	–	﹤0.01%	1914
2025 Q1	$7.65K	Sell	84 -100	-54%	-$11.2K	﹤0.01%	1933
2024 Q4	$21K	Buy	184 +129	+235%	+$14.7K	﹤0.01%	1520
2024 Q3	$6.53K	Hold	55	–	–	﹤0.01%	1911
2024 Q2	$4.42K	Hold	55	–	–	﹤0.01%	1192
2024 Q1	$5.07K	Buy	+55	New	+$5.27K	﹤0.01%	1912
2022 Q4	$6.52K	Buy	+43	New	+$6.62K	﹤0.01%	1670
2022 Q3	–	Sell	-43	Closed	-$6K	–	717
2022 Q2	$6K	Buy	+43	New	+$6.57K	﹤0.01%	1601
2022 Q1	–	Sell	-201	Closed	-$52K	–	730
2021 Q4	$52K	Buy	+201	New	+$55K	﹤0.01%	982

Other funds holding BNTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

CCP

Crocodile Capital Partners Ursensollen, Germany $160M AUM 18.68% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

TAA

TB Alternative Assets Grand Cayman, Cayman Islands $488M AUM 102.53% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

CoreCap Advisors's BNTX Position: Q3 2026 in Review

CoreCap Advisors held its BioNTech (BNTX) position steady in Q3 2026 at 84 shares worth $8.26K. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

CoreCap Advisors first reported a position in BNTX in Q4 2021 and has held it in 14 quarters since. The position peaked at $52K in Q4 2021. 39 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

CoreCap Advisors held 84 shares of BioNTech worth $8.26K as of Q3 2026.
CoreCap Advisors left its BioNTech share count unchanged in Q3 2026.
BioNTech made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2120 holding.
CoreCap Advisors first reported a position in BioNTech in Q4 2021 and has held it in 14 quarters since.
CoreCap Advisors's BioNTech position peaked at $52K in Q4 2021.
39 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.